Literature DB >> 30301693

Three-dimensional image fusion is associated with lower radiation exposure and shorter time to carotid cannulation during carotid artery stenting.

Nicholas J Swerdlow1, Douglas W Jones2, Alexander B Pothof3, Thomas F X O'Donnell1, Patric Liang1, Chun Li1, Mark C Wyers1, Marc L Schermerhorn4.   

Abstract

OBJECTIVE: Three-dimensional (3D) image fusion is associated with lower radiation exposure, contrast agent dose, and operative time during endovascular abdominal aortic aneurysm repair. Therefore, we evaluated the impact of this technology on carotid artery stenting (CAS).
METHODS: We identified consecutive CAS procedures from 2009 to 2017 and compared those performed with and without 3D image fusion. For image fusion, we created a 3D reconstruction of the aortic arch anatomy based on preoperative computed tomography or magnetic resonance angiography that we merged with two-dimensional fluoroscopy, allowing 3D image overlay. We compared radiation exposure, fluoroscopy time, contrast agent dose, time to common carotid artery (CCA) cannulation, time from CCA cannulation to completion angiography, and total procedure time in procedures with and without image fusion. We also assessed rates of 30-day stroke/death, in-hospital and 30-day stroke, and acute kidney injury. We used multivariable linear regression to adjust for patient and procedural characteristics and used these models to compute the marginal effects of image fusion compared with no image fusion.
RESULTS: There were 46 patients who underwent CAS with a 3D image fusion system and 70 patients without. Patients undergoing CAS with image fusion experienced 31% lower radiation exposure compared with the control group (207 ± 23 mGy vs 300 ± 26 mGy, respectively; P < .01), shorter fluoroscopy time (21 ± 6 minutes vs 24 ± 8 minutes; P = .02), shorter time to carotid cannulation (21 ± 9 minutes vs 31 ± 8 minutes; P < .001), and shorter total procedure time (47 ± 13 minutes vs 54 ± 18 minutes; P = .03). There was no difference in contrast material volume, time from CCA cannulation to completion angiography, or total in-room time. After multivariable adjustment, 3D image fusion remained associated with lower radiation dose, shorter fluoroscopy time, and shorter time to carotid cannulation (all P < .05). The rate of 30-day stroke/death was 2.7% (three strokes and no deaths at 30 days), and the rate of acute kidney injury was 1.8%.
CONCLUSIONS: CAS with 3D image fusion was associated with lower radiation exposure and shorter time to CCA cannulation. These results represent the potential technical advantage gained with image fusion and add to the growing body of evidence demonstrating its impact on radiation exposure and operative times during complex endovascular procedures.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carotid artery stenting; Image fusion; Radiation exposure

Mesh:

Year:  2018        PMID: 30301693     DOI: 10.1016/j.jvs.2018.07.038

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Magnetic Resonance Angiography and Cisternography fused images in acute ischemic stroke may save time during endovascular procedure revealing vessel anatomy.

Authors:  Enricomaria Mormina; Agostino Tessitore; Marco Cavallaro; Antonio Armando Caragliano; Orazio Buonomo; Mirta Longo; Francesca Granata; Michele Caponnetto; Sergio Lucio Vinci
Journal:  Heliyon       Date:  2022-08-17

Review 2.  Augmented Reality in Vascular and Endovascular Surgery: Scoping Review.

Authors:  Joshua Eves; Dimitri Amiras; Abhilash Sudarsanam; Joseph Shalhoub
Journal:  JMIR Serious Games       Date:  2022-09-23       Impact factor: 3.364

3.  Accuracy of registration techniques and vascular imaging modalities in fusion imaging for aortic endovascular interventions: a phantom study.

Authors:  M M Sieren; C Schareck; M Kaschwich; M Horn; F Matysiak; E Stahlberg; F Wegner; T H Oechtering; J Barkhausen; J Goltz
Journal:  CVIR Endovasc       Date:  2021-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.